Back

Predictors of non-participation and dropout during outpatient cardiac rehabilitation

11 April 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Cardiovascular Rehabilitation and Exercise Testing Cardiovascular Rehabilitation EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Mr Rutger Brouwers

Catharina Hospital, Eindhoven (Netherlands (The))

59 More presentations in this session

Presentation thumbnail
Usefulness of percent-predicted oxygen uptake efficiency slope to detect patients with real functional capacity impairment and submaximal cardiopulmonary exercise test
Doctor A. Berenguel (Toledo, ES)
Abstract
Presentation thumbnail
Is cardiac rehabilitation useful in preventing a recurrence of atrial fibrillation or the need for a second ablation within 1 year after the first ablation?
Miss G. Geebelen (Hasselt, BE)
Abstract Slides
Presentation thumbnail
Improvement of 6-minute walking distance after phase II cardiac rehabilitation program in postoperative grown-up congenital heart (GUCH) disease patients: a 10-year experience
Doctor B. Dwiputra (Jakarta, ID)
Abstract Slides
Presentation thumbnail
Holistic effects in multi-modal comprehensive short-term cardiac rehabilitation - preliminary results from the OutCaRe-registry
Doctor A. Salzwedel (Potsdam, DE)
Abstract Slides
Presentation thumbnail
A lifestyle and self-care focused smartphone application can improve risk factor outcomes in cardiac rehabilitation for patients after myocardial infarction
Mrs H. Ogmundsdottir Michelsen (Helsingborg, SE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Cardiovascular Rehabilitation and Exercise Testing

The Event

Event poster

EuroPrevent 2019

11 April - 13 April 2019
You may be interested in
thumbnail
Congress Session
How to prescribe exercise for people with valvular heart disease or hypertension
thumbnail
Congress Presentation
How should we prescribe exercise – and who should do it?
thumbnail
Congress Presentation
Exercise and cardiovascular risk: friend or foe? - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources